2 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
Follow CHOP: new trials by email Literature Review of CHOP trials Research Report on CHOP
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL) Zandelisib, Rituximab, Bendamustine - Follicular Lymphoma (FL), Non Hodgkin Lymphoma | Phase 3 | Terminated | MEI Pharma, Inc. | 82 | 2021-08-13 | 2024-11-04 |
| A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma Bevacizumab, Rituximab, CHOP - B-cell Lymphoma | Phase 3 | Terminated | Hoffmann-La Roche | 787 | 2007-07-26 | 2017-07-25 |
Lymphoma, B-Cell (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Follicular (1) · Lymphoma, Non-Hodgkin (1)
Hoffmann-La Roche (1) · MEI Pharma, Inc. (1)
Australia (2) · Canada (2) · France (2) · Greece (2) · Hungary (2) · Italy (2) · New Zealand (2) · Poland (2) · South Korea (2) · Spain (2) · Taiwan (2) · United Kingdom (2) · United States (2) · Argentina (1) · Austria (1)